Glioma is a tumor formed by neuroglial cells, which support neurons.
The 2016 revision of the WHO criteria includes molecular information-based classification criteria in addition to conventional morphological diagnostic criteria. Researches have called attention to IDH (Isocitrate Dehydrogenase) 1/2 genes, ATRX gene, mutation in TERT promoter, and 1p/19q co-deletion as factors for molecular diagnosis of glioma.
We provide a wide range of monoclonal antibodies appropriate for immunohistochemical staining/western blotting to recognize wild-type/mutant IDH1, IDH2, ATRX, and TERT.